Records containing: Primary Sclerosing Cholangitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
-
CLINICAL_TRIALS study record update · 2026-04-22A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis
-
CLINICAL_TRIALS study record update · 2026-04-06A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase II, Multicenter, Double-Blind, Randomised, Placebo-Controlled Study and Open Label Long Term Extension to Evaluate the Safety and Efficacy of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis (PSC).
-
CLINICAL_TRIALS study record update · 2026-03-20Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-13A Phase II Study to Evaluate Safety, Tolerability and Efficacy, of CS0159 in Patients Subjects With Primary Sclerosing Cholangitis, Multicenter, Randomized, 12-week Double-blind, Placebo-controlled, and 40-week Open Study
-
CLINICAL_TRIALS study record update · 2026-03-12A Randomized, Placebo-controlled Pilot Study of Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (PSC)
-
CLINICAL_TRIALS study record update · 2026-03-12A Pilot Study Examining a Vegan/Low-Sulfur Diet Versus the Specific Carbohydrate Diet in Patients With Primary Sclerosing Cholangitis
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Sponsor-Open Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-781 in Healthy Participants and a Single-Arm, Open-Label Evaluation in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis
-
CLINICAL_TRIALS study record update · 2026-02-27The Effect of Statin Therapy on Bile Acid Physiology and the Microbiome in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
-
CLINICAL_TRIALS study record update · 2026-02-17Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
-
CLINICAL_TRIALS study record update · 2026-02-17A Resource of Blood and Other Biospecimens of Patients With Cholestatic Liver Disease and Unaffected Individuals
-
CLINICAL_TRIALS study record update · 2026-02-04A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
-
CLINICAL_TRIALS study record update · 2026-01-23A Randomized, Double-blind, Dose-ranging, Placebo-controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Primary Sclerosing Cholangitis (PSC) and Suspected Liver Fibrosis (INTEGRIS-PSC)
-
CLINICAL_TRIALS study record update · 2026-01-08Effect of Gluten-free Diet on Clinical Symptoms, Immune Response and Microbiome in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2025-12-01Repeatability and Reproducibility of Multiparametric MRI (LiverMultiScan)
-
CLINICAL_TRIALS study record update · 2025-11-24A 12-Month, Open-Label Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Siplizumab as Induction Therapy in Patients With Autoimmune Liver Diseases Undergoing Liver Transplantation (SET-SAIL)
-
CLINICAL_TRIALS study record update · 2025-11-06Detoxification of the Liver in Primary Sclerosing Cholangitis
-
CLINICAL_TRIALS study record update · 2025-09-08Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
-
CLINICAL_TRIALS study record update · 2025-09-05Effect of Simvastatin on the Prognosis of Primary Sclerosing Cholangitis (PSC); A Randomized, Double-blind, Placebo Controlled Multicenter Study
-
CLINICAL_TRIALS study record update · 2025-08-26Usage of TruGraf Liver Gene Expression to Identify Subclinical Rejection as Well as Adjust Immunosuppression Medications in Liver Transplant Recipients Due to Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2025-07-30An Open Label, Phase 2 Study to Evaluate the Effect of A3907 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults With Primary Sclerosing Cholangitis (PSC)
-
CLINICAL_TRIALS study record update · 2025-07-25A Prospective, Randomized, Placebo-controlled Clinical Trial of Oral Vancomycin in Adults and Young Adults (15-17 Years Old) Affected by Primary Sclerosing Cholangitis With or Without Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2025-07-24Autoimmune Liver Disease Network for Kids (A-LiNK): Using Patient Data to Transform Care and Improve Outcomes for Children, Adolescents, and Young Adults With Autoimmune Liver Disease
-
CLINICAL_TRIALS study record update · 2025-06-27Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation